Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11 Pt 1
pubmed:dateCreated
2006-6-2
pubmed:abstractText
To evaluate the prognostic value of cyclin E with a quantitative method for lymph node-negative primary breast cancer patients.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1078-0432
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
12
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3319-28
pubmed:meshHeading
pubmed-meshheading:16740753-Adult, pubmed-meshheading:16740753-Aged, pubmed-meshheading:16740753-Breast Neoplasms, pubmed-meshheading:16740753-Cyclin E, pubmed-meshheading:16740753-Cyclins, pubmed-meshheading:16740753-Disease-Free Survival, pubmed-meshheading:16740753-Female, pubmed-meshheading:16740753-Follow-Up Studies, pubmed-meshheading:16740753-Humans, pubmed-meshheading:16740753-Middle Aged, pubmed-meshheading:16740753-Multivariate Analysis, pubmed-meshheading:16740753-Oncogene Proteins, pubmed-meshheading:16740753-Predictive Value of Tests, pubmed-meshheading:16740753-Prognosis, pubmed-meshheading:16740753-RNA, Messenger, pubmed-meshheading:16740753-Retrospective Studies, pubmed-meshheading:16740753-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:16740753-Tumor Markers, Biological
pubmed:year
2006
pubmed:articleTitle
Which cyclin E prevails as prognostic marker for breast cancer? Results from a retrospective study involving 635 lymph node-negative breast cancer patients.
pubmed:affiliation
Department of Medical Oncology, Erasmus MC, Rotterdam, The Netherlands. a.sieuwerts@erasmusmc.nl
pubmed:publicationType
Journal Article